Homoharringtonine
Semisynthetic derivative of harringtonine that acts as a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC.
Year introduced: 2019 (1972)
PubMed search builder options
Subheadings:
Tree Number(s): D03.132.420.500, D03.633.100.079.533.500, D03.633.400.624.500
MeSH Unique ID: D000077863
Registry Number: 6FG8041S5B
Entry Terms:
- Omacetaxine Mepesuccinate
- Cephalotaxine
- Omacetaxine
- Homoharringtonine (3(R))-isomer
- Ceflatonin
- Synribo
Pharmacologic Action: